Trending News
-
Nvidia’s $5 Billion Stake Fuels Intel’s Biggest Rally in Years
Intel shares soared following an announcement that Nvidia will take a $5 billion equity stake…
Read More » -
-
-
-
-
-
-
-
Tech
-
Nvidia’s $5 Billion Stake Fuels Intel’s Biggest Rally in Years
Intel shares soared following an announcement that Nvidia will take a $5 billion equity stake in the company.
Read More » -
Company
ePlus Makes AI Power Play With Realwave Buy — Here’s What It Could Mean
ePlus buys Realwave via OneCloud, adding AI-powered cloud integration to boost security, analytics, and services growth—strengthening its infrastructure-first, consultative strategy…
Read More » -
Company
Elutia’s Game-Changing Tech Has Boston Scientific’s Full Attention— Is A Bigger Deal Coming Next?
Elutia sells EluPro & CanGaroo assets to Boston Scientific for $88M, erasing debt and funding NXT-41—sparking speculation this divestiture could…
Read More »
Biotech
-
Biotech
Eli Lilly’s Obesity Pill Could Be a Game-Changer — But Here’s Why Zepbound Already Has a Giant Lead
Eli Lilly has taken a commanding position in the obesity drug market with its GLP-1 agonist Zepbound, and now the…
Read More » -
Biotech
BioNTech’s High-Stakes Leap Into Cancer: Inside The $1.25 Billion CureVac Deal & Its Oncology Ambitions
BioNTech’s recent $1.25 billion all-stock acquisition of former rival CureVac marks a definitive shift in strategy—away from COVID-19 vaccine reliance…
Read More » -
Biotech
Bristol Myers’ $11.1 Billion Bet on BioNTech: Is Oncology The New Growth Engine?
Bristol Myers has inked a transformative partnership for BNT327, a bispecific PD-L1/VEGF-A antibody developed by BioNTech, with a $1.5 billion…
Read More »
Healthcare
-
Company
Zepp Health’s Bet On Women’s Health With The Wild.AI Buyout: Strategic Leap Or Risky Play?
Zepp Health, best known for its Amazfit smartwatches, has taken a bold step in health-tech with its acquisition of Wild.AI’s…
Read More » -
Company
Phreesia’s $160 Million AccessOne Acquisition: Will This Deal Redefine Healthcare Payments?
Phreesia is charting new territory with its recently announced $160 million all-cash acquisition of AccessOne Parent Holdings, a healthcare financing…
Read More » -
Company
Y-mAbs’ $412 Million Take-Private Offer From SERB Poised To Upset The Oncology Landscape
Y-mAbs Therapeutics stunned investors when SERB Pharmaceuticals announced an all-cash bid to take the company private at $8.60 per share,…
Read More »
-
Cannabis
Grove Inc (GRVI): Untouchable Leader Within the CBD-Based Industry?
Cannabidiol, commonly known as CBD, is a naturally occurring chemical compound found in cannabis plants…
Read More » -
-
-
Follow us on Twitter